LOC100507351: A Drug Target / Disease Biomarker (G100507351)

LOC100507351: A Drug Target / Disease Biomarker

LOC100507351 is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a member of the superfamily of nucleotide-binding proteins (NBP), which are a type of transmembrane protein that can interact with nucleotides such as DNA and RNA.

LOC100507351 is characterized by its unique structure, which consists of a long N-terminus, a catalytic core, and a short C-terminus. The N-terminus of LOC100507351 contains a unique farnesylated cysteine residue, which is a modified form of the amino acid cysteine that can enhance its stability and reduce its sensitivity to inhibitors. The catalytic core of LOC100507351 contains a single beta-sheet and a separate alpha-helices region, which give it a unique 3D structure that is distinct from other NBP proteins. The C-terminus of LOC100507351 contains a single glycophosphoryl group, which is a modified form of the amino acid glycine that can interact with metal ions and play a role in protein-protein interactions.

LOC100507351 has been shown to play a role in various cellular processes, including cell signaling, DNA replication, and metabolism. It has been shown to interact with various proteins, including the transcription factor T-DNA2 and the protein kinase PDK4.

One of the unique features of LOC100507351 is its potential as a drug target. Due to its unique structure and the various functions it has been shown to play, LOC100507351 has been identified as a promising candidate for drug development.

One approach to targeting LOC100507351 is to use small molecules that can modulate its activity. Researchers have synthesized a number of small molecules that can interact with LOC100507351 and have shown that some of these molecules have the ability to enhance its activity.

Another approach to targeting LOC100507351 is to use antibodies that can recognize and label it. Researchers have generated antibodies that can recognize LOC100507351 and have shown that these antibodies can be used to label the protein in various cellular samples.

LOC100507351 is also a potential biomarker for various diseases, including cancer. Its unique structure and various functions make it an attractive candidate for use as a biomarker.

In conclusion, LOC100507351 is a protein that has unique structure and functions, and as a result, it has been identified as a promising candidate for drug development and as a biomarker for various diseases. Further research is needed to fully understand its unique properties and its potential as a drug and biomarker.

Protein Name: Uncharacterized LOC100507351

The "LOC100507351 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC100507351 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC100507389 | LOC100507412 | LOC100507424 | LOC100507443 | LOC100507513 | LOC100507520 | LOC100507547 | LOC100507577 | LOC100507656 | LOC100509646 | LOC100533709 | LOC100630923 | LOC100652743 | LOC100652768 | LOC100652833 | LOC100652999 | LOC100653061 | LOC100996385 | LOC100996412 | LOC100996583 | LOC100996637 | LOC100996643 | LOC100996664 | LOC100996770 | LOC101060017 | LOC101060106 | LOC101060179 | LOC101060400 | LOC101060445 | LOC101060524 | LOC101060632 | LOC101448202 | LOC101593348 | LOC101926887 | LOC101926948 | LOC101926953 | LOC101926959 | LOC101926969 | LOC101927002 | LOC101927020 | LOC101927025 | LOC101927026 | LOC101927040 | LOC101927053 | LOC101927060 | LOC101927066 | LOC101927082 | LOC101927108 | LOC101927143 | LOC101927164 | LOC101927166 | LOC101927169 | LOC101927179 | LOC101927188 | LOC101927199 | LOC101927216 | LOC101927243 | LOC101927245 | LOC101927253 | LOC101927263 | LOC101927269 | LOC101927314 | LOC101927369 | LOC101927394 | LOC101927421 | LOC101927476 | LOC101927483 | LOC101927495 | LOC101927518 | LOC101927531 | LOC101927548 | LOC101927550 | LOC101927571 | LOC101927588 | LOC101927598 | LOC101927605 | LOC101927609 | LOC101927627 | LOC101927636 | LOC101927668 | LOC101927712 | LOC101927727 | LOC101927741 | LOC101927745 | LOC101927770 | LOC101927787 | LOC101927825 | LOC101927827 | LOC101927834 | LOC101927840 | LOC101927853 | LOC101927855 | LOC101927857 | LOC101927863 | LOC101927896 | LOC101927897 | LOC101927910 | LOC101927932 | LOC101927942 | LOC101927947